Last reviewed · How we verify

NCT06728683: ASSIST-MH

Assist MH Digital Technologies to Support School Mental Health Care

Completed NA Last updated 22 January 2026
What this trial tests

NA trial testing ASSIST-MH in Mental Health Strategies in 41 participants. Completed in 18 July 2025.

Timeline
1 April 2025
Primary endpoint
18 July 2025
18 July 2025

Quick facts

Lead sponsor3-C Institute for Social Development
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment41
Start date1 April 2025
Primary completion18 July 2025
Estimated completion18 July 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

3-C Institute for Social Development

Who can join

12 and older, any sex, with Mental Health Strategies or School Mental Health Services. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this SBIR is to develop and test Assist-MH, a new interactive digital support system for SMH providers. Assist-MH will offer SMH treatment resources to help providers implement a more customized treatment plan specific to the student's needs. Based on student areas of need, the system will deliver both provider-led MH strategies to optimize time spent with the student and self-paced digital strategies (video, game-based, interactive) for students to augment in-person treatment and provide unique between-session learning and practice.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other 3-C Institute for Social Development trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06728683.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing